Founding Chairman
Founding
Even if dust accumulates, it must settle on this land.
Former Chairman Mogam Young-Sup Huh was a pioneer in the localization of essential medicines, devoting all his efforts to developing new drugs that would benefit public health rather than profitable treatments.
While studying in Germany in the 1960s, former Chairman Mogam Young-Sup Huh was saddened by Korea's healthcare environment. After returning to Korea in 1970, he founded Green Cross and worked to localize essential medicines that had been dependent on imports.
He also successfully led the development of medicines such as hepatitis B vaccine, and with the funds he raised, he established the Mogam Biotechnology Research Institute (now Mogam Institute for Biomedical Research) as a private research foundation to contribute to the development of domestic science.
"Even if dust accumulates, it must settle on this land."
Former Chairman Mogam Young-Sup Huh practiced his belief that research achievements and personnel would remain in Korea only if a research institute was established in Korea, even if the environment was harsh.
As a CEO from RWTH Aachen University in Germany, former Chairman Mogam Young-Sup Huh successfully led his company and pioneered Korea's biotechnology industry, which was virtually barren land.
He also contributed greatly to promoting friendly cooperation between Korea and Germany through private diplomatic activities, and was the first foreigner to receive the most honorable title of 'Ehrensenator' that RWTH Aachen University can award.
Founding Chairman
'Enriching the Earth' - the meaning of Former Chairman Huh's pen name
Former Chairman Mogam Young-Sup Huh did not hesitate to support Korean students studying abroad and domestic research foundations. When he heard that RWTH Aachen University, known as 'Europe's MIT,' lacked reading rooms for students to study freely, he donated 1 million euros personally and established 'MOGAM Haus' in 2007.
Former Chairman Mogam Young-Sup Huh, who passed away at age 68 in 2009, donated two-thirds of his stocks and estate to scholarship and research foundations, setting a social example until the very end.
Former Chairman Mogam Young-Sup Huh devoted his entire life to building a sustainable biopharmaceutical industry for the benefit of the Korean people. He was an outstanding biopharmaceutical executive who always emphasized corporate social responsibility.
The achievements of former Chairman Mogam Young-Sup Huh will transcend borders and contribute to improving the lives of people around the world.